Medicine
Halog 0.1% cream
Halog 0.1% cream is a prescription medicine containing Halcinonide for topical use, marketed by Sun Pharmaceutical Industries, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Halcinonide
- Brand
- Halog
- Strength
- 0.1%
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube, 4 tubes, 216 g and 2 more
- Marketing authorisation holder
- Sun Pharmaceutical Industries
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaGenus Lifesciences
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D07AD02 Halcinonide
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 February 2009
- Identifiers
- RxCUI 103467, 206546DailyMed set ID 484c3224-edd1-db3e-e063-6294a90abc25, e60d0691-0628-4c98-9a17-f4a89822baf2NDC 64950-126, 10631-094Application NDA017556
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 30 g in 1 tube | 10631-094-20 | Sun Pharmaceutical IndustriesIndia | 10 February 2009 |
| 1 tube in 1 carton / 60 g in 1 tube | 10631-094-30 | Sun Pharmaceutical IndustriesIndia | 10 February 2009 |
| 4 tube in 1 carton / 60 g in 1 tube | 10631-094-71 | Sun Pharmaceutical IndustriesIndia | 2 July 2018 |
| 216 g in 1 jar | 10631-094-76 | Sun Pharmaceutical IndustriesIndia | 10 February 2009 |
| 1 tube in 1 carton / 60 g in 1 tube | 64950-126-06 | Genus Lifesciences | 13 January 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 November 1974 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Halcinonide 0.1% cream.
Other strengths and forms of Halcinonide
Clinical summary
Halcinonide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is available as cream and topical solution. MedsAcross supplies Halcinonide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HalcinonideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Halog prescribing information (Genus Lifesciences) · U.S. National Library of Medicine, DailyMed
Need Halog 0.1% cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.